Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of MCI-186 in Subjects With Severe Hepatic Impairment vs Normal Hepatic Function
NCT03664544Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 1, open-label trial of edaravone (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Peak Drug Concentration, Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Concentration and 1 more. Started Nov 2018; status: completed.
02
Drugs
edaravone
Beyond the preview
Go deeper on NCT03664544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664544.